| Dr Nirav Mistry, MD | |
|
94 Old Short Hills Rd, Livingston, NJ 07039-5672 | |
| (973) 322-2782 | |
| Not Available |
| Full Name | Dr Nirav Mistry |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 19 Years |
| Location | 94 Old Short Hills Rd, Livingston, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912162066 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 249612 (New York) | Secondary |
| 207RC0200X | Internal Medicine - Critical Care Medicine | 25MA09076600 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Michael's Medical Center | Newark, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Avenue Professional Services, Pc | 7214258003 | 41 |
News Archive
Life Technologies Corporation today announced that its scientists have teamed with researchers from Stanford University School of Medicine, and other institutions to discover a genomic component that plays a key role in promoting breast cancer progression. A study published today in the journal Nature details how levels of a specific kind of non-coding RNA molecule in primary breast tumors regulate metastasis and tumor invasiveness and may be an important target for cancer diagnosis and therapy.
With the 2010 midterm election season fast approaching, Democrats are using the health care reform debate to instill unity in their caucus — especially with freshmen lawmakers.
The Methodist Hospital in Houston is excited to share significant news for patients who need treatment for hepatitis C genotype 1, a viral infection that causes liver inflammation that can lead to diminished liver function or symptoms for liver failure.
Tobacco-related diseases are the most preventable cause of death worldwide; smoking cessation leads to improvement in cancer treatment outcomes, as well as decreased recurrence. According to the American Cancer Society, in 2015, nearly 171,000 of the estimated 589,430 cancer deaths in the United States-more than 25 percent-will be caused by tobacco smoking.
Finesse Solutions, LLC, San Jose, CA, a manufacturer of measurement and control solutions for life sciences process applications, announced the release of the T700™ upstream processing platform for single-use bioreactors ranging from 25L to 2,000L in size. The T700 family of turn-key control systems is designed to the highest performance and quality standards.
› Verified 3 days ago
| Entity Name | Sbmc Department Of Critical Care Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720036577 PECOS PAC ID: 7719083682 Enrollment ID: O20070917000471 |
News Archive
Life Technologies Corporation today announced that its scientists have teamed with researchers from Stanford University School of Medicine, and other institutions to discover a genomic component that plays a key role in promoting breast cancer progression. A study published today in the journal Nature details how levels of a specific kind of non-coding RNA molecule in primary breast tumors regulate metastasis and tumor invasiveness and may be an important target for cancer diagnosis and therapy.
With the 2010 midterm election season fast approaching, Democrats are using the health care reform debate to instill unity in their caucus — especially with freshmen lawmakers.
The Methodist Hospital in Houston is excited to share significant news for patients who need treatment for hepatitis C genotype 1, a viral infection that causes liver inflammation that can lead to diminished liver function or symptoms for liver failure.
Tobacco-related diseases are the most preventable cause of death worldwide; smoking cessation leads to improvement in cancer treatment outcomes, as well as decreased recurrence. According to the American Cancer Society, in 2015, nearly 171,000 of the estimated 589,430 cancer deaths in the United States-more than 25 percent-will be caused by tobacco smoking.
Finesse Solutions, LLC, San Jose, CA, a manufacturer of measurement and control solutions for life sciences process applications, announced the release of the T700™ upstream processing platform for single-use bioreactors ranging from 25L to 2,000L in size. The T700 family of turn-key control systems is designed to the highest performance and quality standards.
› Verified 3 days ago
| Entity Name | Garden State Healthcare Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700014545 PECOS PAC ID: 8426190687 Enrollment ID: O20100126000693 |
News Archive
Life Technologies Corporation today announced that its scientists have teamed with researchers from Stanford University School of Medicine, and other institutions to discover a genomic component that plays a key role in promoting breast cancer progression. A study published today in the journal Nature details how levels of a specific kind of non-coding RNA molecule in primary breast tumors regulate metastasis and tumor invasiveness and may be an important target for cancer diagnosis and therapy.
With the 2010 midterm election season fast approaching, Democrats are using the health care reform debate to instill unity in their caucus — especially with freshmen lawmakers.
The Methodist Hospital in Houston is excited to share significant news for patients who need treatment for hepatitis C genotype 1, a viral infection that causes liver inflammation that can lead to diminished liver function or symptoms for liver failure.
Tobacco-related diseases are the most preventable cause of death worldwide; smoking cessation leads to improvement in cancer treatment outcomes, as well as decreased recurrence. According to the American Cancer Society, in 2015, nearly 171,000 of the estimated 589,430 cancer deaths in the United States-more than 25 percent-will be caused by tobacco smoking.
Finesse Solutions, LLC, San Jose, CA, a manufacturer of measurement and control solutions for life sciences process applications, announced the release of the T700™ upstream processing platform for single-use bioreactors ranging from 25L to 2,000L in size. The T700 family of turn-key control systems is designed to the highest performance and quality standards.
› Verified 3 days ago
| Entity Name | Central Avenue Professional Services, Pc |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1447649694 PECOS PAC ID: 7214258003 Enrollment ID: O20150604002544 |
News Archive
Life Technologies Corporation today announced that its scientists have teamed with researchers from Stanford University School of Medicine, and other institutions to discover a genomic component that plays a key role in promoting breast cancer progression. A study published today in the journal Nature details how levels of a specific kind of non-coding RNA molecule in primary breast tumors regulate metastasis and tumor invasiveness and may be an important target for cancer diagnosis and therapy.
With the 2010 midterm election season fast approaching, Democrats are using the health care reform debate to instill unity in their caucus — especially with freshmen lawmakers.
The Methodist Hospital in Houston is excited to share significant news for patients who need treatment for hepatitis C genotype 1, a viral infection that causes liver inflammation that can lead to diminished liver function or symptoms for liver failure.
Tobacco-related diseases are the most preventable cause of death worldwide; smoking cessation leads to improvement in cancer treatment outcomes, as well as decreased recurrence. According to the American Cancer Society, in 2015, nearly 171,000 of the estimated 589,430 cancer deaths in the United States-more than 25 percent-will be caused by tobacco smoking.
Finesse Solutions, LLC, San Jose, CA, a manufacturer of measurement and control solutions for life sciences process applications, announced the release of the T700™ upstream processing platform for single-use bioreactors ranging from 25L to 2,000L in size. The T700 family of turn-key control systems is designed to the highest performance and quality standards.
› Verified 3 days ago
| Entity Name | Sbmc Provider Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942748983 PECOS PAC ID: 8729344569 Enrollment ID: O20171109003416 |
News Archive
Life Technologies Corporation today announced that its scientists have teamed with researchers from Stanford University School of Medicine, and other institutions to discover a genomic component that plays a key role in promoting breast cancer progression. A study published today in the journal Nature details how levels of a specific kind of non-coding RNA molecule in primary breast tumors regulate metastasis and tumor invasiveness and may be an important target for cancer diagnosis and therapy.
With the 2010 midterm election season fast approaching, Democrats are using the health care reform debate to instill unity in their caucus — especially with freshmen lawmakers.
The Methodist Hospital in Houston is excited to share significant news for patients who need treatment for hepatitis C genotype 1, a viral infection that causes liver inflammation that can lead to diminished liver function or symptoms for liver failure.
Tobacco-related diseases are the most preventable cause of death worldwide; smoking cessation leads to improvement in cancer treatment outcomes, as well as decreased recurrence. According to the American Cancer Society, in 2015, nearly 171,000 of the estimated 589,430 cancer deaths in the United States-more than 25 percent-will be caused by tobacco smoking.
Finesse Solutions, LLC, San Jose, CA, a manufacturer of measurement and control solutions for life sciences process applications, announced the release of the T700™ upstream processing platform for single-use bioreactors ranging from 25L to 2,000L in size. The T700 family of turn-key control systems is designed to the highest performance and quality standards.
› Verified 3 days ago
| Entity Name | Rwjbh Observation Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760095806 PECOS PAC ID: 5193137503 Enrollment ID: O20201209000008 |
News Archive
Life Technologies Corporation today announced that its scientists have teamed with researchers from Stanford University School of Medicine, and other institutions to discover a genomic component that plays a key role in promoting breast cancer progression. A study published today in the journal Nature details how levels of a specific kind of non-coding RNA molecule in primary breast tumors regulate metastasis and tumor invasiveness and may be an important target for cancer diagnosis and therapy.
With the 2010 midterm election season fast approaching, Democrats are using the health care reform debate to instill unity in their caucus — especially with freshmen lawmakers.
The Methodist Hospital in Houston is excited to share significant news for patients who need treatment for hepatitis C genotype 1, a viral infection that causes liver inflammation that can lead to diminished liver function or symptoms for liver failure.
Tobacco-related diseases are the most preventable cause of death worldwide; smoking cessation leads to improvement in cancer treatment outcomes, as well as decreased recurrence. According to the American Cancer Society, in 2015, nearly 171,000 of the estimated 589,430 cancer deaths in the United States-more than 25 percent-will be caused by tobacco smoking.
Finesse Solutions, LLC, San Jose, CA, a manufacturer of measurement and control solutions for life sciences process applications, announced the release of the T700™ upstream processing platform for single-use bioreactors ranging from 25L to 2,000L in size. The T700 family of turn-key control systems is designed to the highest performance and quality standards.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nirav Mistry, MD 94 Old Short Hills Rd, Livingston, NJ 07039-5672 Ph: (973) 322-2782 | Dr Nirav Mistry, MD 94 Old Short Hills Rd, Livingston, NJ 07039-5672 Ph: (973) 322-2782 |
News Archive
Life Technologies Corporation today announced that its scientists have teamed with researchers from Stanford University School of Medicine, and other institutions to discover a genomic component that plays a key role in promoting breast cancer progression. A study published today in the journal Nature details how levels of a specific kind of non-coding RNA molecule in primary breast tumors regulate metastasis and tumor invasiveness and may be an important target for cancer diagnosis and therapy.
With the 2010 midterm election season fast approaching, Democrats are using the health care reform debate to instill unity in their caucus — especially with freshmen lawmakers.
The Methodist Hospital in Houston is excited to share significant news for patients who need treatment for hepatitis C genotype 1, a viral infection that causes liver inflammation that can lead to diminished liver function or symptoms for liver failure.
Tobacco-related diseases are the most preventable cause of death worldwide; smoking cessation leads to improvement in cancer treatment outcomes, as well as decreased recurrence. According to the American Cancer Society, in 2015, nearly 171,000 of the estimated 589,430 cancer deaths in the United States-more than 25 percent-will be caused by tobacco smoking.
Finesse Solutions, LLC, San Jose, CA, a manufacturer of measurement and control solutions for life sciences process applications, announced the release of the T700™ upstream processing platform for single-use bioreactors ranging from 25L to 2,000L in size. The T700 family of turn-key control systems is designed to the highest performance and quality standards.
› Verified 3 days ago
Bilal Khan, Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 94 Old Short Hills Rd, Livingston, NJ 07039 Phone: 646-591-5953 | |
Dr. Bruce Joseph Haik, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 94 Old Short Hills Road Suite 2511, Livingston, NJ 07039 Phone: 973-731-9442 Fax: 973-731-2918 | |
Parvathy Thiruwilwamala, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 94 Old Short Hills Rd, Livingston, NJ 07039 Phone: 973-322-5000 | |
Dr. Michael Gutkin, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 349 E Northfield Rd, Suite 202, Livingston, NJ 07039 Phone: 973-597-1107 Fax: 973-597-1407 | |
Dr. Eugene Ludwig Evans Jr., M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 2 W Northfield Rd, Suite 211, Livingston, NJ 07039 Phone: 973-758-0044 Fax: 973-758-0055 | |
Dr. Stuart E Baskin, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 315 E Northfield Rd, Suite 1a, Livingston, NJ 07039 Phone: 973-994-2121 Fax: 973-535-8191 | |
Jill Ritter, MD Critical Care Medicine Medicare: May Accept Medicare Assignments Practice Location: 200 S Orange Ave, Livingston, NJ 07039 Phone: 973-322-7400 Fax: 973-322-7420 |